Benzinga | Jan 21, 2022 06:27AM EST

HC Wainwright & Co. Maintains Neutral on BioDelivery Sciences Intl, Raises Price Target to $4.5

HC Wainwright & Co. analyst Oren Livnat maintains BioDelivery Sciences Intl (NASDAQ:BDSI) with a Neutral and raises the price target from $4 to $4.5.